Voyager Therapeutics (VYGR) Other Working Capital Changes (2014 - 2026)

Voyager Therapeutics has disclosed Other Working Capital Changes across 13 years of filings, most recently posting -$1.2 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$1.2 million, down 37.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$29.1 million (up 37.35% YoY), and the FY2025 annual result was -$28.8 million, up 35.76% from the prior year.
• Other Working Capital Changes came in at -$1.2 million for Q1 2026 at Voyager Therapeutics, up from -$23.4 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $17.0 million in Q3 2022 to a low of -$43.1 million in Q4 2024.
• The 5-year median for Other Working Capital Changes is -$868000.0 (2025), against an average of -$5.4 million.
• Peak annual rise in Other Working Capital Changes reached 1268.38% in 2022, while the deepest fall reached 67900.0% in 2022.
• Voyager Therapeutics' Other Working Capital Changes stood at -$25.8 million in 2022, then surged by 135.1% to $9.1 million in 2023, then sank by 575.57% to -$43.1 million in 2024, then soared by 45.65% to -$23.4 million in 2025, then soared by 94.9% to -$1.2 million in 2026.
• The last three Other Working Capital Changes figures came in at -$1.2 million (Q1 2026), -$23.4 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.